This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $5,983.12 firm fixed-price contract is for the supply of 4,566,062,897 units of VYVANSE 60 mg capsules. The contract has an ultimate completion date of October 10, 2024 and is not associated with a set-aside program. AmerisourceBergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
This is a firm fixed price delivery order valued at $8,085.00 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for 4,563,424,694 units of VYVANSE 20 MG CAPSULE 100S, a pharmaceutical product. The contract has a completion date of January 23, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, has received numerous federal contract awards to supply pharmaceuticals...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office Division. The $31,222.78 fixed-price order is for the supply of 4,566,006,924 units of the pharmaceutical product VYVANSE CAPS 60MG. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025 that AmerisourceBergen holds with DLA Troop Support Medical for a comprehensive range of medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $26,648.30 firm fixed-price contract is for the supply of 4,565,612,730 capsules of the pharmaceutical product VYVANSE 40MG. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which provides a broad range of medical...
This is a delivery order under contract SPE2DX15D3014 awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4,564,311,852 units of the prescription drug VYVANSE 20 MG CAPSULE 100S, with a ceiling value of $5,467.95. The contract is for a firm fixed price with an ultimate completion date of April 16, 2024. This delivery order does not have a set-aside designation....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The $6,189.79 firm fixed-price contract is for the supply of 4,565,594,284 units of the prescription drug VYVANSE 40 MG CAPSULE 100S. The contract has an ultimate completion date of August 23, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $1,927.20 firm-fixed-price contract is for the delivery of 4,565,638,359 units of the prescription drug VYVANSE 30 MG CAPSULE 100S. The order has an ultimate completion date of August 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit global pharmaceutical sourcing and distribution company. The contract is for the supply of 4,563,515,890 units of the drug VYVANSE 40 MG CAPSULE 100S, with a completion date of February 2, 2024. The potential value of this delivery order is $2,624.97. This order is not associated with any...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,297,530 units of the pharmaceutical product VYVANSE 30 MG CAPSULE 100S. The order, which has a potential value of $1,724.00, was awarded on January 10, 2024 with a completion date of January 11, 2024. No set-aside designation was used. Amerisourcebergen Drug Corporation, as a prime contractor, has previously...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of 4,565,365,428 units of VYVANSE 40 MG CAPSULE 100S. The contract has a ceiling value of $1,231.86 and is a firm-fixed price delivery order type. The period of performance extends through August 7, 2024. This order is not associated with a set-aside program. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts...